HIKAL
Back to All Ratios
|
HIKAL Last 5 Year Payable days History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Payable days | 131.04 | 92.70 | 87.68 | 86.55 | 84.90 |
What is the latest Payable days ratio of HIKAL ?
Year | Payable days |
---|---|
Mar2024 | 131.04 |
Mar2023 | 92.70 |
Mar2022 | 87.68 |
Mar2021 | 86.55 |
Mar2020 | 84.90 |
How is Payable days of HIKAL Trending?
Years | Payable days | % Change | |
---|---|---|---|
Mar2024 | 131.04 | 41.36 | |
Mar2023 | 92.7 | 5.73 | |
Mar2022 | 87.68 | 1.31 | |
Mar2021 | 86.55 | 1.94 | |
Mar2020 | 84.9 | - |
Other Financial Ratios of HIKAL
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Payable days ratio of peers of HIKAL
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
HIKAL | ₹3,210.1 Cr | 2.1% | -17.2% | -18.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹379,659.0 Cr | -0.7% | -3.6% | -13.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,886.0 Cr | 0.3% | -5.5% | 22.4% | Stock Analytics | |
CIPLA | ₹127,435.0 Cr | -0.8% | 4.1% | -4.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,719.0 Cr | 1.1% | -0.5% | 5.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,610.0 Cr | -0.8% | 2.3% | -8.1% | Stock Analytics |
HIKAL Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
HIKAL | 2.1% |
-17.2% |
-18.9% |
SENSEX | 0.8% |
0.2% |
-2% |
You may also like the below Video Courses